Clinical trials have begun of antipsychotic treatments in persons who are p
rodromally symptomatic and at high risk for schizophrenia but who have not
yet become psychotic. The ethical issues connected with intervening prior t
o making a diagnosis of psychosis are detailed. Compelling but tentative ev
idence suggests that early treatment may improve course and prognosis, and
this has initiated a paradigm shift in thinking about the risks and benefit
s of early intervention. The nature of this evidence, its implications, its
shortcomings, and its effect upon the ethics of treating schizophrenia are
elaborated and discussed. It is concluded that clinical psychiatry is curr
ently in a state of "equipoise" or genuine uncertainty about the comparativ
e merits of early treatment, a state which endorses early intervention rese
arch, including intervention in the prodromal phase. (C) 2001 Elsevier Scie
nce B.V. All rights reserved.